Previous 10 | Next 10 |
2024-05-01 20:46:08 ET Jazz Pharmaceuticals plc (JAZZ) Q1 2024 Earnings Conference Call May 01, 2024 4:30 PM ET Company Participants Andrea Flynn – Vice President and Head-Investor Relations Bruce Cozadd – Chairman and Chief Executive Officer Ren...
2024-05-01 16:23:44 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals: Cheap But Complicated Jazz Pharmaceuticals: Targeting The Low-Hanging Fruit In Oncology Might Pay Off Avadel surges after royalty rate awarded to Jazz in patent dispute lower than requested (up...
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference PR Newswire DUBLIN , May 1, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the BofA Securities 2024 Gl...
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance PR Newswire – 12% year-over-year revenue increase from combined key growth drivers: Xywav ® , Epidiolex ® and Rylaze ® – – On...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
2024-04-30 17:20:33 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals: Cheap But Complicated Jazz Pharmaceuticals: Targeting The Low-Hanging Fruit In Oncology Might Pay Off Jazz Pharmaceuticals PLC (JAZZ) Q4 2023 Earnings Call Transcript Avadel surges afte...
2024-04-30 16:00:00 ET Summary Harmony Biosciences Holdings, Inc. stock price fell sharply in October last year, as the lead drug pitolisant - approved to treat narcolepsy - missed endpoints in a late stage IH study. The company's Q3 2023 earnings saw Wakix revenues up 37% YoY and...
NORTHAMPTON, MA / ACCESSWIRE / April 30, 2024 / Jazz Pharmaceuticals: At Jazz, Earth Month provides an opportunity to reflect on steps we can take to become more conscious of our actions to positively impact the planet. For more information on our approach to sustainable practices, read our Co...
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024 PR Newswire Overall survival and additional long-term follow-up data from the Phase 2b HERIZON-BTC-01 trial in previously treated HER2-positive metastatic biliary tract cancer ...
Originally published by Jazz Pharmaceuticals NORTHAMPTON, MA / ACCESSWIRE / April 23, 2024 / Purple Day spotlights epilepsy and the challenges that people face when living with the condition. Jazz wants the epilepsy community know that they are not alone and showed support by sporting pu...
News, Short Squeeze, Breakout and More Instantly...
Jazz Pharmaceuticals plc Company Name:
JAZZ Stock Symbol:
NASDAQ Market:
Jazz Pharmaceuticals plc Website:
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 38.2% to $0.24 on volume of 498,894,705 shares Qualigen Therapeutics Inc. (QLGN) rose 59.5% to $0.28 on volume of 243,116,946 shares NVIDIA Corporation (NVDA) fell 1.9% to $125.83 on volume o...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 109.0% to $0.3668 on volume of 102,385,159 shares Maxeon Solar Technologies Ltd. (MAXN) rose 4.3% to $0.181 on volume of 66,422,365 shares NVIDIA Corporation (NVDA) fell 1.3% to $126.58 on volume...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 4.6% to $128.28 on volume of 215,349,874 shares Zoomcar Holdings Inc. (ZCAR) rose 34.0% to $0.183 on volume of 204,010,215 shares Maxeon Solar Technologies Ltd. (MAXN) fell 3.5% to $0.1736 on volume of 2...